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Strengths and limitations of this study
 ► This mixed methodology will rely on a closely coor-
dinated combination of methods and on the utilisa-
tion of valuable existing data underexploited to date 
(patients’ electronic hospital records and Resident 
Assessment Instrument-Home Care (RAI-HC) data).
 ► The investigation draws on an interprofessional and 
interdisciplinary approach, which associates gen-
eral practitioners, community healthcare nurses, 
pharmacists and researchers in health psychology, 
old age psychiatry, nursing and survey methodology.
 ► Our findings will contribute to the development of an 
evidence-based and innovative, cooperative mod-
el of medication management for polymedicated, 
home-dwelling older adults with multiple chronic 
conditions.
 ► Although patients’ electronic hospital records and 
RAI-HC data provide a broad range of patient-re-
lated, medication-related and environment-related 
information, they rarely highlight factors that may 
influence the occurrence of medication-related 
problems.
ABSTRACT
Introduction Optimal medication management is one of 
the basic conditions necessary for home-dwelling older 
adults living with multiple chronic conditions (OAMCC) 
to be able to remain at home and preserve their quality 
of life. Currently, the reasons for such high numbers of 
emergency department visits and the very significant rate 
of hospitalisations for OAMCC, due to medication-related 
problems (MRPs), is poorly explored. This study aims to 
reveal the current state of the medication management 
practices of polymedicated, home-dwelling OAMCC and 
to make proposals for improving clinical and medication 
pathways through an innovative and integrated model 
for supporting medication management and preventing 
adverse health outcomes.
Methods and analysis A mixed-methods study will 
address the medication management of polymedicated, 
home-dwelling OAMCC. Its explanatory sequential design 
will involve two major phases conducted sequentially over 
time. The quantitative phase will consist of retrospectively 
exploiting the last 5 years of electronic patient records from 
a local hospital (N ≈ 50 000) in order to identify the different 
profiles—made up of patient-related, medication-related 
and environment-related factors—of the polymedicated, 
home-dwelling OAMCC at risk of hospitalisation, emergency 
department visits, hospital readmission (notably for MRPs), 
institutionalisation or early death. The qualitative study will 
involve: (a) obtaining and understanding the medication 
management practices and experiences of the identified 
profiles extracted from the hospital data of OAMCC who 
will be interviewed at home (N ≈ 30); (b) collecting and 
analysing the perspectives of the formal and informal 
caregivers involved in medication management at home in 
order to cross-reference perspectives about this important 
dimension of care at home. Finally, the mixed-methods 
findings will enable the development of an innovative, 
integrated model of medication management based on the 
Agency for Clinical Innovation framework and Bodenheimer 
and Sinsky’s quadruple aim.
Ethics and dissemination Ethical approval has been 
obtained from the Human Research Ethics Committee 
of the Canton Vaud (2018-02196). Findings will be 
disseminated in peer-reviewed journals, professional 
conferences and other knowledge transfer activities with 
primary healthcare providers, hospital care units, informal 
caregivers’ and patients’ associations.
InTRoduCTIon
The number of older adults living at home 
with multiple chronic conditions (OAMCC) 
rises considerably around the world and has 
been estimated to affect 25.2% of people 
aged from 65 to 79% and 41.3% of those aged 
80 and over.1 Multiple chronic conditions is 
a comprehensive concept used to properly 
cover the diverse definitions of multimor-
bidity2 3 and therefore the complexity of 
older adults’ health statuses. The concept 
encompasses the simultaneous presence of 
an individual’s diseases and their chronic 
physical, mental or behavioural health prob-
lems requiring ongoing management over 
years or decades.4
These long-term health conditions require 
taking multiple medications,5 known as 
polypharmacy (PP) when the daily intake 
Infirm
iers. Protected by copyright.
 o
n
 N
ovem
ber 12, 2019 at HES-SO
 Valais-W
allis - Fili?re Soins
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030030 on 28 October 2019. Downloaded from 
2 Pereira F, et al. BMJ Open 2019;9:e030030. doi:10.1136/bmjopen-2019-030030
Open access 
corresponds to five or more medicines.6 PP places older 
adults at higher risk of medication-related problems 
(MRPs), including adverse medication reactions, medica-
tion errors and potentially inappropriate medications.7 8 
Potentially inappropriate medications are the intake of 
medicines for which the associated risks outweigh the 
potential benefits, particularly when more effective alter-
natives are available.9 Consequently, MRPs can lead to 
a degradation of the patient’s clinical condition, phys-
ical and cognitive decline, an exacerbation of chronic 
medical conditions and avoidable health costs.10 11 More-
over, up to 25% of emergency department visits by home-
dwelling OAMCC are due to MRPs.10 However, 60% of 
MRPs in patients visiting the emergency department with 
non-specific complaints (such as weakness) may go undi-
agnosed, whereas 83% of those MRPs may be responsible 
for acute morbidity.10 MRPs are also a frequent cause 
of readmission, and they were the most frequent cause 
in one study that followed older patients for 6 months 
after hospital discharge.12 Care-coordination problems, 
associated with low or suboptimal medication manage-
ment, are all the more evident in the sensitive period of 
discharge home from hospital.11 13 The complexity of 
OAMCC’s care needs leads them to be significant users 
of health services and to consult many different health-
care professionals.14 The number of healthcare profes-
sionals consulted by home-dwelling OAMCC has been 
directly associated with fragmented and uncoordinated 
care.13 Moreover, different healthcare professionals may 
have different treatment preferences. Failure to coordi-
nate care among home-dwelling OAMCC contributes to 
MRPs.13
In addition to the role of healthcare professionals in 
medication management, informal caregivers play a vital 
role in ensuring safe and appropriate medication use by 
home-dwelling OAMCC, especially among those who may 
also have cognitive impairment.15–17 Despite the important 
role of informal caregivers in medication management, 
several complications to do with their activities have been 
documented in relation to the time spent, anxiety making 
a mistake and the uncooperative behaviour of the home-
dwelling OAMCC.18 They are also confronted with diffi-
culties in maintaining continuous supplies of medication, 
assisting with administration, making clinical judgements 
(eg, in response to side effects and about over-the-counter 
medication), and solving conflictual communications or 
disagreements with the older adult,18 or even with health-
care professionals, with regard to ineffective and addic-
tive medication practices.15 18
Nonetheless, many MRPs are preventable.8 10 19 Studies 
about medicine-related hospitalisations suggest that up to 
58% may be preventable with appropriate primary care.8 
An essential strategy for medicine-related hospitalisations 
prevention and medication safety is medication reconcil-
iation—the process of creating and maintaining a single 
list of the patient’s current list of medications.20 This 
process allows a systematic and comprehensive review 
of all the medications the patient is taking, reducing 
medication errors by a consistent communication across 
transitions of care.21
Therefore, optimising medication management among 
home-dwelling OAMCC requires regular monitoring of 
MRPs, interprofessional collaboration across different 
health and social care providers, organisations and depart-
ments13 and medication reconciliation at every transition 
of care including changes in the clinical setting, practi-
tioner or level of care.22
Aim and objectives
This study’s aim is to document the current state of medi-
cation management practices of polymedicated, home-
dwelling OAMCC and to make proposals for improving 
evidence-based clinical and medication pathways through 
an innovative, integrated model intended to support 
medication management and to prevent adverse health 
outcomes related to MRPs (recurrent hospitalisation, 
emergency department visits, institutionalisation in 
nursing homes and early death). To achieve this aim, 
three main objectives will guide this project:
The first objective is to carry out a retrospective analysis 
of patients’ hospital records, their medication and envi-
ronment-related factors in order to identify those that 
increase the risk of hospitalisation, emergency depart-
ment visits, hospital readmission (notably due to MRPs), 
institutionalisation or early death, among home-dwelling 
polymedicated OAMCC—factors that prevent OAMCC 
from staying at home.
The second objective is to use a prospective qualitative 
study to explore and better understand the medication expe-
riences and practices of home-dwelling OAMCC with different 
profiles. We seek to identify the skills and strategies devel-
oped by them to manage polymedication within their 
social contexts and health trajectories despite possible 
cognitive impairment and particularly after a recent 
hospitalisation.
The third objective is to better understand the roles and 
coordination of the different caregivers involved in the medica-
tion management of home-dwelling OAMCC. We seek to inves-
tigate the perspectives of both professional caregivers 
(community healthcare nurses, pharmacists, general 
practitioners or specialist physicians) and non-profes-
sional/informal caregivers (family members, friends or 
neighbours).
METhodS
Study design
To enable us to meet our objectives, a mixed-methods 
study will address the medication management of poly-
medicated, home-dwelling OAMCC.23 Two major phases 
will be conducted sequentially from February 2019 
to January 2022: a quantitative data collection phase 
followed by a qualitative phase. The reasons for using 
an explanatory sequential design are, first, that existing 
data in electronic patient records from a local hospital 
will enable us to identify profiles affected by similar 
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patient-related, medication-related and environment-re-
lated factors among the polymedicated, home-dwelling 
OAMCC at risk of hospitalisation, emergency depart-
ment visits, hospital readmission (notably due to MRPs), 
institutionalisation or early death. Second, the identi-
fied profiles extracted from the hospital data will allow 
proceeding to a purposive sampling—of those polymed-
icated, home-dwelling OAMCC who present with more 
risk factors—for the qualitative data collection focused 
on medication management at home. Thus, the anal-
ysis of the results from the retrospective quantitative 
phase will be integrated with the data collected from the 
prospective qualitative phase. Finally, phase 3 will develop 
a Medication Management Model based on interpreting 
the quantitative and qualitative findings.
Phase 1: retrospective quantitative analysis
To fulfil the first objective, the purpose of the quantita-
tive phase is to identify the different profiles—made up of 
patient-related, medication-related and environment-re-
lated factors—of the polymedicated, home-dwelling 
OAMCC at risk of hospitalisation, emergency department 
visits, hospital readmission (notably for MRPs), institu-
tionalisation in nursing homes or early death (before the 
average age of death described by the Organisation for 
Economic Cooperation and Development in 2018).24 A 
systematic, retrospective chart analysis of the electronic 
patient records from a local hospital over the last 4 years 
using the evidence-based methodology developed by 
Vassar and Holzmann will provide substantial clinical 
information.25 Motheral et al’s standardised extraction 
sheets will be adapted to explore and assess the data of 
older inpatients or emergency department-visiting home-
dwelling older adults.26 The 4-year analysis was selected 
based on the availability of systematic, well-coded patient 
data using the Swiss-Diagnostic Related Groups27 and the 
Swiss Classification of Surgical Interventions (CHOP).28
Research population
All home-dwelling OAMCC with somatic and/or mental 
health disorders who were hospitalised, rehospitalised 
or who consulted the emergency department (for MRPs 
or other reasons) at the partner hospital between 2015 
and 2018 (estimated n=50 000) will be included. The esti-
mated sample of 50 000 older adults’ electronic inpatient 
charts are part of the 40 000 yearly adult inpatients in 
acute care units and more than 40 000 adult emergency 
department consultations yearly at the partner hospital. 
To explore generalisability, we will compare their sociode-
mographic and health status characteristics with those of 
the national sample of hospitalised older adults in Swiss 
hospitals for the same period.
Data collection
Data from the hospitalisation and emergency admissions 
databases will be collected on patient-related, medica-
tion-related and environment-related factors that could 
have influenced the occurrence of MRPs that resulted in 
hospitalisation, rehospitalisation or emergency depart-
ment admission.
Patient-related factors comprise sociodemographic 
characteristics, the International Classification of Diseases 
10th version (ICD-10) diagnostics (main diagnosis and 
comorbidities), the Swiss Classification of Surgical Inter-
ventions (CHOP) category and the reason for hospi-
talisation, rehospitalisation or emergency department 
admission. Supplementary filters will be added to discrim-
inate polymedication, multimorbidity (secondary ICD-10 
diagnosis), physical and cognitive impairment docu-
mented in the clinical data files (Function Independence 
Measure, Mini-Mental State Examination and Activities of 
Daily Living).
Medication-related factors include the number, types 
and changes in medication at admission, during hospital-
isation and at discharge.
Environment-related factors include the presence of 
formal and/or informal caregivers, patient’s provenance 
(rural or urban), hospital pathways (wards and even-
tual transfers), length of stay, readmissions (number of 
admissions in the previous year, 30-day readmission and 
unplanned readmission), discharge destination and, 
potentially, death during hospitalisation. A unique patient 
identification number will allow us to analyse rehospital-
isations via the emergency department during the period 
from 2015 to 2018. Retrospective data collection began 
in April 2019.
Data analyses
The data set of polymedicated, home-dwelling OAMCC 
will be analysed using multivariate regression analysis, 
in order to identify the patient-related, medication-re-
lated and environment-related factors that can increase 
the risk of hospitalisation, emergency department visits, 
readmission (notably due to MRPs), institutionalisation 
or early death. Furthermore, the profiles of polymedi-
cated, home-dwelling OAMCC hospitalised or visiting 
the emergency department due to MRPs, and identified 
via multicluster analysis, will serve to guide the qualita-
tive study and lead to a purposive sampling of polymedi-
cated, home-dwelling OAMCC presenting with more risk 
factors. A draft of the cluster analysis strategy is available 
as an online supplementary file.
Phase 2: prospective patient-centred qualitative analysis
To meet the second and third objectives, a qualitative 
investigation, based on purposive sampling, will draw on 
work done in a feasibility study.29 This qualitative inves-
tigation will consist of collecting and understanding 
the medication practices and experiences of OAMCC 
presenting with the risk factors identified in the first 
phase. The focus will be on identified OAMCC who were 
recently hospitalised and are at risk of hospital readmis-
sion. The older adult will be interviewed at home on two 
separate occasions. This methodology is a way to analyse 
changes in their medication practises and their experi-
ences following their recent hospitalisation. The data 
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Table 1 Phase 2 inclusion and exclusion criteria
Participants Inclusion criteria Exclusion criteria
OAMCC  ► Aged 65 or above
 ► Man or woman
 ► Hospitalised within the last 90 days
 ► Managing at least five different 
medications (prescribed and over-the-
counter medications explored during 
recruitment)
 ► Suffering from multiple chronic 
conditions4
 ► Living alone or in a couple, in a rural or 
urban area
 ► With or without support from a 
Community Healthcare Centre
 ► Not able to speak and understand 
French
Informal caregiver  ► Designated by the OAMCC as the 
most significant informal caregiver 
involved in medication management
 ► Aged 18 or above
 ► Not able to speak and understand 
French
Professional caregiver  ► Designated by the OAMCC as having a 
key role in medication management
 ► Student
 ► Apprentice
OAMCC, older adults living with multiple chronic conditions.
collection tools include a walking-interview30 based on 
a medication journal and household photographs of 
where medication is stored. This allows us to focus on the 
tangible practices of OAMCC and contextualises them 
within the private space of their daily lives.
To discriminate the older adults’ health profile, we 
will use the Resident Assessment Instrument-Home Care 
(RAI-HC) introduced by the Swiss Association for Home 
Care Services for all home care services in 2004. Based on 
a comprehensive geriatric assessment, the RAI-HC both 
allows for the establishment of an individualised care 
plan and generates quality indicators, plans resource use, 
optimises the medication management process by moni-
toring and documenting the number and types of medi-
cation and the persons involved in preparing medication, 
and regularly assesses adherence to the medication 
prescribed.31 This instrument will provide information 
on the patient-related, medication-related and environ-
ment-related factors which may influence the occurrence 
of MRPs, and it will be used to recruit OAMCC at risk of 
or already presenting with MRPs.
Furthermore, we will also collect and analyse the 
perspectives of the formal and informal caregivers 
involved in medication management at home to cross-ref-
erence perspectives about this important dimension of 
care at home.
Research population
The profiles of the polymedicated OAMCC hospitalised/
rehospitalised or consulting the emergency department, 
as identified in the retrospective investigation, will be 
used to select participants for the qualitative investiga-
tion. A theoretical, purposive sampling will be carried 
out. Based on Guest et al, the principal investigator will 
recruit about 30 polymedicated OAMCC (until saturation 
of data), all recently hospitalised (within the last 90 days) 
and at risk of hospital readmission.32 For each OAMCC 
participant, an informal caregiver will also be integrated 
into the investigation. We defined informal caregivers 
as any family member, neighbour or friend assisting a 
dependent older adult with certain activities in their daily 
life. That assistance, help, care or physical presence must 
be given on a regular basis, for at least two basic activi-
ties or instrumental activities of daily living or to ensure 
patient safety, and for 6 months or more.33 The informal 
caregiver will be included in the study if the recruited 
older adult identifies that person as being significant in 
their medication management and if they give informed 
written consent to participate.
Furthermore, a formal caregiver will be integrated 
into the investigation for each participant. Professional 
caregivers are those employed to provide professional 
healthcare services (ie, nurses, nursing assistants, general 
practitioners, pharmacists and social workers). They will 
be included in the study if the recruited OAMCC identi-
fies them as the professional most involved in their medi-
cation management.
Table 1 presents the specific inclusion/exclusion 
criteria for each group of participants.
Participant recruitment
Polymedicated, home-dwelling OAMCC will be recruited 
via two paths so that all of the participants meet the eligi-
bility criteria and fit corresponding profiles established in 
the quantitative phase. Some OAMCC will be receivers of 
care from Community Healthcare Centres and others will 
be functioning without that day-to-day support.
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 ► For OAMCC who do not receive support from a 
Community Healthcare Centre, recruitment will be 
based on variables in their patient files and carried 
out in collaboration with different nursing depart-
ments from the partner hospital.
 ► For OAMCC who do receive support from a Commu-
nity Healthcare Centre, recruitment will be based 
on the clinical and health data documented in the 
RAI-HC and carried out in collaboration with commu-
nity healthcare nurses from Sion Community Health-
care Centre.
Research nurses partnering the project, from a hospital 
or a Community Healthcare Centre, will briefly explain 
the study to the patient. Potential participants will be 
asked for permission to give their name to the researchers. 
The principal investigator will contact the older adult by 
telephone during the week following hospital discharge 
and ask for their agreement to participate in the study. 
In case of agreement, a first meeting will be organised at 
the older adult’s home in the next few days. Participant 
recruitment will start in October 2019.
Data collection from OAMCC
During the first home meeting with the OAMCC, the 
principal investigator will provide all the study details and 
will suggest two semistructured interviews, each lasting 
about an hour, starting on the first meeting and spaced 
2–3 weeks apart. According to participants’ levels of tired-
ness, it may be necessary to subdivide the interviews. The 
older adult will be invited to sign the informed written 
consent form, allowing the researcher to collect sociode-
mographic and health data (RAI-HC and the patient’s 
hospital records). Eligible home-dwelling OAMCC from 
both recruitment paths will be screened using the RAI-HC 
Minimal Data Set (MDS), which includes information on 
polymedication (section P), multiple chronic conditions 
(sections J and K) and recent hospitalisation (section Ac). 
Research team members trained on the RAI-HC will also 
carry out this evaluation for participants who do not have 
an RAI-HC. The following multidimensional clinical data 
will be retrieved from the RAI-HC MDS: cognitive status, 
hearing, vision, mood status, functional and physical 
status, continence, healthcare problems and nutritional 
state. The MDS will aid interviews with OAMCC and the 
exploration of the facilitators and barriers to daily medi-
cation management.
The first semistructured interview will collect the 
perspectives of OAMCC with regard to their medi-
cation management, the return home, information 
received about their treatment and its possible modifi-
cations, whether their opinions and preferences were 
taken into account in the prescription of medications, 
and the informal and professional caregivers involved. 
OAMCCs will be interviewed alone or with an informal 
caregiver, if necessary. The principal investigator will 
then ask the participant to complete a week-long medi-
cation journal,34 35 either alone or with the help from 
informal or professional caregivers, emphasising that any 
information on daily medication routines is helpful, even 
if the OAMCC feels unable to complete the journal for 
the full 7 days. The instructions will mention the impor-
tance of noting all the medicines taken—those prescribed 
by general practitioners or specialist physicians, but also 
any others taken at their own initiative (over-the-counter 
medications). Participants will be asked to note their 
perceptions of and satisfaction with their treatment in 
a week-long medication journal. This will provide infor-
mation on the daily routines associated with the partici-
pant’s medication and will form the basis of the second 
interview.
The second interview will be based on the participant’s 
medication journal and will take the form of a walking-in-
terview36 using household photographs.35 The principal 
investigator will ask the participant to explain their medi-
cation practises while pointing out the locations within 
their home where drugs are stored, prepared and taken. 
The hypothesis underlying this methodology is that the 
physical presence of drugs promotes discussion.37 38 We 
will identify and photograph, with the participants’ agree-
ment, the places where medication, contact details for 
medical professionals and other information are stored 
as well as the locations of any other objects involved in 
daily care practises. The collection and analysis of photo-
graphs provide a better understanding of the complexity 
of medication management in home settings. They help 
to capture the interviewee’s concerns or strategies when 
they are pointed out to the interviewer. The interview 
guide will also investigate the issue of self-medication in 
order to reveal the extent and influence of this practice.
Data collection from informal caregivers
Sociodemographic data and information related to medi-
cation management will be collected. When possible and 
appropriate, a joint third interview39 with the OAMCC and 
their principal informal caregiver34 will be organised at 
the older adult’s home 1–2 weeks after the walking inter-
view. This type of interview provides access to the inter-
actions between OAMCC and their informal caregivers 
with regard to medication management. We hypothesise 
that the main informal caregiver is deeply involved in the 
older adult’s experience of medication management, but 
the caregiver’s ideas about this may be similar to, overlap-
ping with or different from those of an OAMCC.
Data collection from professional caregivers
A semistructured interview of about 1 hour will be 
conducted with a professional caregiver in order to 
explore their point of view on the OAMCC’s medication 
management and other issues associated with the return 
home after hospitalisation. In agreement with the proj-
ect’s field partners and stakeholders, these interviews 
will take place in professionals’ workplaces (Community 
Healthcare Centre, medical practice office or pharmacy), 
during working hours, 1–2 weeks after the interview with 
the OAMCC and their informal caregiver.
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Table 2 Outcomes for each study phase
Phase 1 
outcomes
Patient-related, medication-related and 
environment-related factors which can increase 
the risk of hospitalisation, emergency department 
visits, hospital readmission (notably due to MRPs), 
institutionalisation or early death.
Profiles of polymedicated, home-dwelling 
OAMCC hospitalised or visiting the emergency 
department due to MRPs based on the previously 
identified patient-related, medication-related and 
environment-related factors.
Phase 2 
outcomes
For OAMCC participants:
 ► Patient-related, medication-related and 
environment-related factors for MRPs (defined 
by phase 1’s outcomes) extracted from the 
RAI-HC MDS and the patient’s electronic 
hospital records (number and types of 
medication, multiple chronic conditions, recent 
hospitalisations, cognitive status, hearing, 
vision, mood status, functional and physical 
status, continence, healthcare problems and 
nutritional state).
 ► Medication practices and experiences of 
OAMCC following their recent hospitalisation, 
facilitators/barriers to medication management, 
informal and professional caregivers involved.
For informal caregivers:
 ► Sociodemographic profiles.
 ► Practices and experiences related to medication 
management.
For professional caregivers:
 ► Sociodemographic and professional profiles.
 ► Role and perspectives on OAMCC medication 
management.
 ► Coordination activities related to returning home 
after hospitalisation.
Phase 3 
outcomes
Three first steps in the process of developing a 
Model of Care43:
 ► ‘Project initiation’.
 ► ‘Diagnostic’.
 ► ‘Solution design’ considering the quadruple 
aim.
Proposals for the Medication Management Model’s 
‘Implementation’ and ‘Sustainability’ steps43 to 
support medication management and to prevent 
adverse health outcomes related to MRPs.
MDS, Minimal Data Set; MRPs, medication-related problems; 
OAMCC, older adults living with multiple chronic conditions; 
RAI-HC, Resident Assessment Instrument-Home Care.
Qualitative data analyses
A database will be prepared using the RedCap software 
platform to record and store the participants’ sociodemo-
graphic, health and interview data. Information on their 
health statuses will be collected using the RAI-HC data 
and will be analysed using the IBM-Statistical Package for 
Social Sciences V.25.0.
Data collected via the interviews will be examined 
according to an analytical plan that integrates and 
compares two different methods. First, thematic content 
analysis,40 41 using NVivo V.12 software, will be used to 
identify the themes emerging from the data, and this will 
provide a rich, detailed account of the data set. Themes 
will be compared by different members of the analysis 
team until a consensus is reached. Second, lexicometric 
analysis, using Iramuteq software—a technique derived 
from the Alceste method42—will allow a very fine explo-
ration, both within each interview and across the whole 
corpus of interviews, of the structures underlying the 
discourse. Each older adult’s medication journal will be 
analysed and categorised according to the same prin-
ciples as the interviews. The data collected from these 
documents will be put into perspective by the analysis 
of the interviews. In the final data analysis, links will be 
made between the interviews, the medication journal, the 
older adult’s RAI-HC data and the photos of the medi-
cines’ locations.
Phase 3: development of a medication management model
Connecting retrospective and prospective findings, 
using an explanatory sequential design and participants’ 
different perspectives, will contribute to a deep under-
standing of the current state of medication management 
practices of polymedicated, home-dwelling OAMCC. This 
mixed-methods study corresponds to the ‘diagnostic’ 
phase of the process of developing a Model of Care, as 
presented by the Agency for Clinical Innovation (ACI).43 
It will guide the ‘solution design’ phase—the next step 
in the creation of an innovative, integrated model for 
supporting medication management and preventing 
adverse health outcomes. In addition to the ACI’s 
framework, the development of a proposed Medication 
Management Model will consider the quadruple aim of 
enhancing the patient’s experience, improving popula-
tion health, reducing costs and improving the working 
lives of healthcare providers.44
Finally, our mixed-methods research findings will be 
completed with those of an ongoing systematic review of 
Medication Management Models.45
The study phase outcomes are summarised in table 2.
Patient and public involvement
This study and the feasibility study on which it is based 
were developed in collaboration with representatives from 
a Community Healthcare Centre, a regional hospital, 
medical and pharmacy associations and an informal care-
givers association. They shared their expertise on the 
study’s relevance and the feasibility of data collection with 
the research team. Patients’ priorities, experiences and 
preferences, collected during the feasibility study, were 
the drivers for the development of the research question 
and outcome measures.
A steering committee will involve these different 
actors at various stages in the project, both to contribute 
to data collection and to provide their expertise to the 
coconstruction of a Medication Management Model 
and its future implementation. As regards data collec-
tion, the hospital’s medical informatics department will 
provide the appropriate data based on a data extraction 
protocol (phase 1) and the Community Healthcare 
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Centre will help with OAMCC recruitment and access 
to participants’ RAI-HC and professional caregivers 
(phase 2).
Results will be disseminated to study participants 
through presentations to associations of patients and 
informal caregivers and at professional training sessions.
EThICS And dISSEMInATIon
With the approval, the medical informatics department 
of partner hospital will provide the appropriate data 
for the retrospective phase based on a data extraction 
protocol. Extracted data will be delivered and stored in 
the ReDCap data platform via a secure coded data file. In 
coherence with the Data Management Plan submitted to 
the Swiss National Science Foundation, the collected data 
will be securely stored for future research.
The autonomy of the participants will be respected. 
Participation in the prospective phase in this research is 
free. It will be possible for participants to refuse to record 
the interview or to request the deletion of the recorded 
data. Participating in a structured effort to understand 
medication practises and the posthospital return home 
experience can contribute to improvements in health 
management in the community at large, and particularly 
in the area of home support.
Findings will be disseminated in peer-reviewed jour-
nals, professional conferences and other knowledge 
transfer activities with primary healthcare providers, 
hospital care units, informal caregiver and patient 
associations.
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